Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs

Int J Mol Sci. 2023 Nov 1;24(21):15874. doi: 10.3390/ijms242115874.

Abstract

Glial-cell-line-derived neurotrophic factor (GDNF) family ligands (GFLs) contribute to the sensitization of primary afferents and are involved in the pathogenesis of inflammatory pain. The purpose of this preliminary study was to examine the expression of other GFLs (neurturin (NRTN), artemin (ARTN), persephin (PSPN)) and receptors in human IVD cells and tissues exhibiting early and advanced stages of degeneration. Human IVD cells were cultured as a monolayer after isolation from the nucleus pulposus (NP) and anulus fibrosus (AF) tissues. The mRNA expression of NRTN, ARTN, PSPN, and their receptors (GFRA2-GFRA4) was quantified using real-time PCR. Protein expression was evaluated using immunohistochemistry and Western blotting. The expression of NRTN, ARTN, PSPN, and their co-receptors (GFRA2-GFRA4) was identified in human IVD cells at both mRNA and protein levels. A trend was noted wherein the mRNA expression of ARTN, PSPN, and GFRA2 was upregulated by IL-1β treatment in a dose-dependent manner. The percentages of immunopositive cells in the advanced degenerate stage of ARTN, PSPN, and GFRA2 were significantly higher than those in the early degenerate stage. Their expression was enhanced in advanced tissue degeneration, which suggests that GFLs (ARTN and PSPN) may be involved in the pathogenesis of discogenic pain.

Keywords: glial-cell-line-derived neurotrophic factor family ligands; human; intervertebral disc degeneration.

MeSH terms

  • Glial Cell Line-Derived Neurotrophic Factor Receptors / genetics
  • Glial Cell Line-Derived Neurotrophic Factor* / metabolism
  • Humans
  • Intervertebral Disc* / metabolism
  • Pain
  • RNA, Messenger / genetics
  • Transforming Growth Factor beta

Substances

  • Glial Cell Line-Derived Neurotrophic Factor
  • Transforming Growth Factor beta
  • RNA, Messenger
  • GFRA4 protein, human
  • Glial Cell Line-Derived Neurotrophic Factor Receptors

Grants and funding

This research received no external funding.